Online citations, reference lists, and bibliographies.
← Back to Search

Chemical Aspects Of Metoprolol Metabolism. Asymmetric Synthesis And Absolute Configuration Of The 3-[4-(1-hydroxy-2-methoxyethyl)phenoxy]-1-(isopropylamino)-2-propanols , The Diastereomeric Benzylic Hydroxylation Metabolites.

H. Shetty, W. L. Nelson
Published 1988 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Asymmetric synthesis of 3-[4-(1-hydroxy-2-methoxyethyl)phenoxy]-1-(isopropylamino)-2-propanol (2), the benzylic hydroxylation metabolite of metoprolol (1), is described, and the absolute configurations of the diastereoisomers were assigned. Ketone 3, prepared in a multistep synthesis, was reduced with a complex of (2S)-(-)-2-amino-3-methyl-1,1-diphenylbutan-1-ol (9) and borane, yielding 2, with a ratio of 82:18 for the diastereomers. The absolute configurations 1'S,2S and 1'S,2R were assigned for the diastereomers formed in excess on the basis of reductions on closely related alkyl phenyl ketones and the circular dichroism spectrum. Derivatization of the 1'-hydroxyl group of oxazolidinone 10 with a chiral Mosher acid chloride and the use of an HPLC procedure to resolve the resulting esters enabled us to determine the metabolic product stereoselectivity for 2. In the presence of the rat liver microsomal fraction, the benzylic hydroxylation of 1 was highly product stereoselective favoring 1'R stereochemistry at the new asymmetric center in racemic 1 and in both enantiomers of 1. Determination of the stereochemistry of 2 will facilitate study of this polymorphically controlled metabolic process.



This paper is referenced by
10.1016/j.bmcl.2011.02.003
Furostanol saponins from the rhizomes of Dioscorea japonica and their effects on NGF induction.
K. Kim (2011)
10.1016/B978-0-08-057123-2.50011-9
CHAPTER 7: – Drug Metabolism
R. Silverman (1992)
10.1016/S0378-4347(01)00166-9
Enantiomeric separation of metoprolol and alpha-hydroxymetoprolol by liquid chromatography and fluorescence detection using a chiral stationary phase.
B. Mistry (2001)
10.1002/JLCR.2580271011
Stereospecific synthesis of specifically deuterated metoprolol enantiomers from chiral starting materials
H. Shetty (1989)
10.1016/j.jchromb.2011.09.010
In vitro metabolic stability and metabolite profiling of TJ0711 hydrochloride, a newly developed vasodilatory β-blocker, using a liquid chromatography-tandem mass spectrometry method.
Jiangeng Huang (2011)
10.1016/J.TET.2006.12.016
Concise synthesis of β-blockers (S)-metoprolol and (S)-betaxolol using hydrolytic kinetic resolution
M. Muthukrishnan (2007)
10.1002/CHIR.10244
Stereoselective metabolism of metoprolol: enantioselectivity of alpha-hydroxymetoprolol in plasma and urine.
P. Cerqueira (2003)
10.1016/B978-0-12-382030-3.00008-8
Chapter 8 – Drug Metabolism
R. Silverman (2014)
10.1023/B:RUJO.0000019729.62073.21
α-Halo Ketones in C-, N-, O-, and S-Alkylation Reactions
I. Moiseev (2003)
10.1007/1-4020-4142-X_2
Pathways of Biotransformation — Phase II Reactions
C. Ionescu (2005)
10.1002/047084289X.RA092M
2‐Amino‐3‐methyl‐1,1‐diphenyl‐1‐butanol
D. Mathre (2001)
10.1021/jm9002704
Improvement of pharmacological properties of irreversible thyroid receptor coactivator binding inhibitors.
J. Hwang (2009)
10.1016/0006-2952(90)90466-X
Enantioselective and diastereoselective aspects of the oxidative metabolism of metoprolol.
S. Murthy (1990)
10.1039/C7RA06499C
Kinetic resolution of (RS)-1-chloro-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol: a metoprolol intermediate and its validation through homology model of Pseudomonas fluorescens lipase
S. Soni (2017)
10.1002/JHET.5570280535
Benzofurans. Improved syntheses of bufuralol, 7‐ethyl‐2‐(2‐tert‐butylamino‐1‐hydroxyethyl)benzofuran, and 1″‐oxobufuralol, 7‐acetyl‐2‐(2‐tert‐butylamino‐1‐hydroxyethyl)benzofuran
S. Weerawarna (1991)
10.1039/c2ob26253c
Synthesis, biological evaluation, and structure-activity relationships of tri- and tetrasubstituted olefins related to isocombretastatin A-4 as new tubulin inhibitors.
Jessy Aziz (2013)
10.1007/978-1-4020-9787-4_13
Compounds Derived from Alkoxyacetic Acids
R. Martin (2011)
10.1002/047084289X.RN00969
α‐Bromo‐p‐Hydroxyacetophenone
Richard S Givens (2009)
10.1016/J.TETLET.2011.08.031
Lipase-mediated kinetic resolution of ( RS)-1-bromo-3-[4-(2-methoxy-ethyl)-phenoxy]-propan-2-ol to (
Abhishek Kaler (2011)
Enantioselektive Analyse von chiralen Arzneistoffen, personal care -Produkten und deren jeweiligen Transformationsprodukten in der aquatischen Umwelt
S. Selke (2010)
10.1021/jacs.8b12874
Catalytic α-Selective Deuteration of Styrene Derivatives.
Thomas R Puleo (2019)
10.1002/EJOC.201600723
Direct Synthesis of α‐Alkoxy Ketones by Oxidative C–O Bond Formation
Hui Yu (2016)
10.1016/B978-0-08-051337-9.50012-2
Chapter 7 – Drug Metabolism
R. Silverman (2004)
10.1007/s00259-006-0277-1
Identification and regional distribution in rat brain of radiometabolites of the dopamine transporter PET radioligand [11C]PE2I
H. Shetty (2006)
10.1016/S0065-7743(08)60860-X
Chapter 32. Mechanistic Aspects of Xenobiotic Metabolism as Related to Drug Design
R. Armstrong (1988)
10.1016/J.JCHROMB.2005.06.038
Stereoselective analysis of metoprolol and its metabolites in rat plasma with application to oxidative metabolism.
V. B. Boralli (2005)
10.1002/chir.20674
Application of kinetic resolution using HCS as chiral auxiliary: novel synthesis of beta-blockers (S)-betaxolol and (S)-metoprolol.
J. Zhang (2009)
10.1007/BF02976449
Enantioselective preparation of metoprolol and its major metabolites
Sang-Hun Jung (2000)
10.1021/jo300850a
A photo-Favorskii ring contraction reaction: the effect of ring size.
Viju Balachandran Kammath (2013)
10.1016/j.bcp.2017.04.031
In vivo &agr;‐hydroxylation of a 2‐alkylindole antagonist of the OXE receptor for the eosinophil chemoattractant 5‐oxo‐6,8,11,14‐eicosatetraenoic acid in monkeys
S. Chourey (2017)
Semantic Scholar Logo Some data provided by SemanticScholar